Literature DB >> 11755616

Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis.

A Joutel1, P Favrole, P Labauge, H Chabriat, C Lescoat, F Andreux, V Domenga, M Cécillon, K Vahedi, A Ducros, F Cave-Riant, M G Bousser, E Tournier-Lasserve.   

Abstract

CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is a small-artery disease of the brain caused by NOTCH3 mutations that lead to an abnormal accumulation of NOTCH3 within the vasculature. We aimed to establish whether immunostaining skin biopsy samples with a monoclonal antibody specific for NOTCH3 could form the basis of a reliable and easy diagnostic test. We compared the sensitivity and specificity of this method in two groups of patients suspected of having CADASIL with complete scanning of mutation-causing exons of NOTCH3 (in a retrospective series of 39 patients) and with limited scanning of four exons that are mutation hotspots (prospective series of 42 patients). In the retrospective series skin biopsy was positive in 21 (96%) of the 22 CADASIL patients examined and negative in all others; in the prospective series, seven of the 42 patients had a positive skin biopsy whereas only four had a mutation detected by limited NOTCH3 scanning. Our immunostaining technique is highly sensitive (96%) and specific (100%) for diagnosis of CADASIL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755616     DOI: 10.1016/S0140-6736(01)07142-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  53 in total

Review 1.  New advances in identifying genetic anomalies in stroke-prone probands.

Authors:  James F Meschia; Bradford B Worrall
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  A 52-year-old man with cognitive decline, seizure and stroke.

Authors:  Jessica E Simon; Jillian Parboosingh; Arthur Clark; David George; Anne-Louise Lafontaine; Michael D Hill
Journal:  CMAJ       Date:  2004-04-27       Impact factor: 8.262

3.  New advances in identifying genetic anomalies in stroke-prone probands.

Authors:  James F Meschia; Bradford B Worrall
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 4.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

5.  Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease.

Authors:  Fabrice Dabertrand; Christel Krøigaard; Adrian D Bonev; Emmanuel Cognat; Thomas Dalsgaard; Valérie Domenga-Denier; David C Hill-Eubanks; Joseph E Brayden; Anne Joutel; Mark T Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 6.  Genetic susceptibility to ischemic stroke.

Authors:  James F Meschia; Bradford B Worrall; Stephen S Rich
Journal:  Nat Rev Neurol       Date:  2011-05-31       Impact factor: 42.937

7.  Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.

Authors:  Tai-Seung Nam; Jin Hee Kim; Chi-Hsuan Chang; Woong Yoon; Yoon Seok Jung; Sa-Yoon Kang; Boo Ahn Shin; Ming-Der Perng; Seok-Yong Choi; Myeong-Kyu Kim
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

Review 8.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

9.  Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.

Authors:  Marie Monet-Leprêtre; Boris Bardot; Barbara Lemaire; Valérie Domenga; Ophélia Godin; Martin Dichgans; Elisabeth Tournier-Lasserve; Michel Cohen-Tannoudji; Hugues Chabriat; Anne Joutel
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

10.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.